4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001181431-15-005383
CIK 0001369786operating
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 5:30 PM ET
Size
5.9 KB
Accession
0001181431-15-005383
Insider Transaction Report
Form 4
YORDON JEFFREY
DirectorChief Executive Officer
Transactions
- Gift
Common Stock
2015-02-27−48,850→ 616,076 total
Holdings
- 48,850(indirect: See Footnote)
Common Stock
- 21,088(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares held by a member of Mr. Yordon's immediate family sharing the same household.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 5:30 PM ET
- Size
- 5.9 KB